Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedVersion metadata updated to add revision v3.5.0 and remove revision v3.4.3.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.0%

- Check32 days agoChange DetectedThe study record was updated on 2026-03-03 and 2026-03-04. These updates add the latest status and details of the trial.SummaryDifference0.2%

- Check40 days agoChange DetectedUpdates on 2026-02-24 and 2026-02-25 added new information to the study record, notably the data sharing plan for individual participant data (IPD) and related study details. Deletions on 2026-02-14 and 2026-02-17 removed older or redundant entries from the page.SummaryDifference0.1%

- Check47 days agoChange DetectedUpdates added on 2026-02-06, 2026-02-14, and 2026-02-17 reflect new timestamps on the study page, while earlier timestamps 2025-08-08, 2026-02-04, and 2026-02-05 were removed. No substantive study content appears to have changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedPage shows a new revision (v3.4.2) with update dates around 2026-02-04 and 2026-02-05; the previously displayed funding-lapse notice has been removed. No study data or core content changes were made.SummaryDifference0.5%

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.